Viridian Therapeutics Inc Cash Flow-to-Debt Ratio
Viridian Therapeutics Inc cash flow-to-debt ratio. Viridian Therapeutics Inc (VRDN) has a Cash Flow-to-Debt Ratio of -0.78x as of March 2026, meaning its operating cash flow of $-119.65 Million could theoretically repay -1% of its total liabilities ($153.01 Million) in one year. See Viridian Therapeutics Inc (VRDN) financial flexibility to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Viridian Therapeutics Inc (2012–2025)
Cash flow-to-debt ratio of Viridian Therapeutics Inc from 2012 to 2025. Historical debt coverage capacity for Viridian Therapeutics Inc across 14 annual periods. Check total reinvestment intensity of Viridian Therapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.
Viridian Therapeutics Inc Cash Flow-to-Debt Ratio by Year (2012–2025)
Viridian Therapeutics Inc cash flow-to-debt ratio by year from 2012 to 2025. Year-by-year debt coverage analysis for Viridian Therapeutics Inc. For the full cash flow conversion analysis, see cash flow conversion of Viridian Therapeutics Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.56x | $-276.39 Million | $177.25 Million | ▲ +52.5% |
| 2024 | -3.28x | $-232.32 Million | $70.76 Million | ▲ +13.7% |
| 2023 | -3.81x | $-184.17 Million | $48.40 Million | ▼ -62.3% |
| 2022 | -2.34x | $-93.84 Million | $40.03 Million | ▲ +31.3% |
| 2021 | -3.41x | $-54.58 Million | $15.99 Million | ▼ -28.6% |
| 2020 | -2.65x | $-29.78 Million | $11.22 Million | ▼ -6.8% |
| 2019 | -2.49x | $-36.06 Million | $14.51 Million | ▼ -37.0% |
| 2018 | -1.81x | $-26.84 Million | $14.80 Million | ▲ +10.1% |
| 2017 | -2.02x | $-28.17 Million | $13.97 Million | ▼ -27.8% |
| 2016 | -1.58x | $-7.23 Million | $4.58 Million | ▲ +43.0% |
| 2015 | -2.77x | $-6.90 Million | $2.49 Million | ▼ -162.4% |
| 2014 | -1.05x | $-2.21 Million | $2.10 Million | ▼ -48.7% |
| 2013 | -0.71x | $-1.17 Million | $1.65 Million | ▼ -176.1% |
| 2012 | -0.26x | $-6.22 Million | $24.22 Million | — |